- Corporate Officers - S
- Starr Christopher M
Insider Trading History of Starr Christopher M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Starr Christopher M since 2005.
This trader's CIK number is 1235470.
At the time of last reporting, Starr Christopher M was the Director of Monopar Therapeutics. (stock ticker symbol MNPR).
Also see all insider trading activities at Monopar Therapeutics.
Note that in the past
STARR CHRISTOPHER M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biomarin Pharmaceutical Inc (BMRN) by Starr Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BMRN | 0 | $0 | 21,142 | $211,420 | 0 | $0 |
Yearly summary of insider trading at Axonyx Inc (RPTP) by Starr Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | RPTP | 0 | $0 | 170,054 | $1,726,578 | 170,054 | $601,990 |
| 2014 | RPTP | 0 | $0 | 312,212 | $3,349,756 | 312,212 | $989,498 |
| 2013 | RPTP | 0 | $0 | 110,088 | $1,397,899 | 110,088 | $308,202 |
| 2012 | RPTP | 0 | $0 | 30,255 | $178,837 | 30,255 | $81,536 |
Yearly summary of insider trading at Monopar Therapeutics (MNPR) by Starr Christopher M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | MNPR | 0 | $0 | 0 | $0 | 2,533 | $0 |
| 2023 | MNPR | 0 | $0 | 0 | $0 | 7,600 | $0 |
| 2022 | MNPR | 0 | $0 | 0 | $0 | 6,469 | $0 |
| 2021 | MNPR | 0 | $0 | 0 | $0 | 2,898 | $0 |
| 2020 | MNPR | 0 | $0 | 0 | $0 | 645 | $0 |
Insider trading activities at 3 companies by Starr Christopher M:
1. Biomarin Pharmaceutical Inc (BMRN)
2. Axonyx Inc (RPTP)
3. Monopar Therapeutics (MNPR)
Table 1. Insider trading of Biomarin Pharmaceutical Inc (BMRN) by Starr Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-12-01 | BMRN | Sale | 10,571 | 10.00 | 105,710 |
| 2005-11-21 | BMRN | Sale | 10,571 | 10.00 | 105,710 |
Table 2. Insider trading of Axonyx Inc (RPTP) by Starr Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-23 | RPTP | Sale | 20,033 | 11.62 | 232,723 |
| 2015-03-23 | RPTP | Option Ex | 20,033 | 3.54 | 70,916 |
| 2015-03-16 | RPTP | Sale | 30,021 | 11.71 | 351,575 |
| 2015-03-16 | RPTP | Option Ex | 30,021 | 3.54 | 106,274 |
| 2015-02-24 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2015-02-24 | RPTP | Sale | 30,000 | 9.52 | 285,660 |
| 2015-02-17 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2015-02-17 | RPTP | Sale | 30,000 | 9.37 | 281,100 |
| 2015-01-22 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2015-01-22 | RPTP | Sale | 30,000 | 9.45 | 283,560 |
| 2015-01-15 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2015-01-15 | RPTP | Sale | 30,000 | 9.73 | 291,960 |
| 2014-12-22 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2014-12-22 | RPTP | Sale | 30,000 | 9.00 | 270,060 |
| 2014-12-15 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2014-12-15 | RPTP | Sale | 30,000 | 8.15 | 244,590 |
| 2014-11-24 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2014-11-24 | RPTP | Sale | 30,000 | 9.97 | 298,980 |
| 2014-11-17 | RPTP | Option Ex | 30,000 | 3.54 | 106,200 |
| 2014-11-17 | RPTP | Sale | 30,000 | 9.91 | 297,240 |
| 2014-10-22 | RPTP | Option Ex | 30,000 | 2.97 | 89,100 |
| 2014-10-22 | RPTP | Sale | 30,000 | 10.25 | 307,440 |
| 2014-10-15 | RPTP | Option Ex | 30,000 | 2.97 | 89,100 |
| 2014-10-15 | RPTP | Sale | 30,000 | 10.04 | 301,050 |
| 2014-09-23 | RPTP | Option Ex | 30,000 | 2.97 | 89,100 |
| 2014-09-23 | RPTP | Sale | 30,000 | 10.21 | 306,450 |
| 2014-09-16 | RPTP | Option Ex | 32,896 | 2.50 | 82,075 |
| 2014-09-16 | RPTP | Sale | 32,896 | 10.60 | 348,598 |
| 2014-03-17 | RPTP | Option Ex | 19,316 | 3.25 | 62,873 |
| 2014-03-17 | RPTP | Sale | 19,316 | 10.79 | 208,323 |
| 2014-02-18 | RPTP | Option Ex | 25,000 | 3.25 | 81,375 |
| 2014-02-18 | RPTP | Sale | 25,000 | 15.26 | 381,550 |
| 2014-01-15 | RPTP | Sale | 25,000 | 15.42 | 385,475 |
| 2014-01-15 | RPTP | Option Ex | 25,000 | 2.84 | 71,075 |
| 2013-12-16 | RPTP | Option Ex | 25,000 | 2.78 | 69,500 |
| 2013-12-16 | RPTP | Sale | 25,000 | 13.36 | 333,950 |
| 2013-11-15 | RPTP | Option Ex | 25,000 | 2.78 | 69,500 |
| 2013-11-15 | RPTP | Sale | 25,000 | 12.29 | 307,175 |
| 2013-10-15 | RPTP | Option Ex | 25,000 | 2.84 | 71,000 |
| 2013-10-15 | RPTP | Sale | 25,000 | 13.77 | 344,300 |
| 2013-09-16 | RPTP | Option Ex | 25,000 | 3.11 | 77,825 |
| 2013-09-16 | RPTP | Sale | 25,000 | 14.21 | 355,175 |
| 2012-12-31 | RPTP | Sale | 10,088 | 5.68 | 57,299 |
| 2012-12-31 | RPTP | Option Ex | 10,088 | 2.02 | 20,377 |
| 2012-09-28 | RPTP | Option Ex | 10,085 | 2.42 | 24,456 |
| 2012-09-28 | RPTP | Sale | 10,085 | 5.39 | 54,358 |
| 2012-06-29 | RPTP | Sale | 10,085 | 5.60 | 56,476 |
| 2012-06-29 | RPTP | Option Ex | 10,085 | 2.83 | 28,540 |
| 2012-04-02 | RPTP | Option Ex | 10,085 | 2.83 | 28,540 |
| 2012-04-02 | RPTP | Sale | 10,085 | 6.74 | 68,003 |
Table 3. Insider trading of Monopar Therapeutics (MNPR) by Starr Christopher M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-31 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2023-09-30 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2023-06-30 | MNPR | Option Ex | 2,534 | .00 | 0 |
| 2023-03-31 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2022-09-30 | MNPR | Option Ex | 2,859 | .00 | 0 |
| 2022-06-30 | MNPR | Option Ex | 2,859 | .00 | 0 |
| 2021-12-31 | MNPR | Option Ex | 751 | .00 | 0 |
| 2021-09-30 | MNPR | Option Ex | 751 | .00 | 0 |
| 2021-06-30 | MNPR | Option Ex | 752 | .00 | 0 |
| 2021-03-31 | MNPR | Option Ex | 751 | .00 | 0 |
| 2020-09-30 | MNPR | Option Ex | 322 | .00 | 0 |
| 2020-12-31 | MNPR | Option Ex | 322 | .00 | 0 |
| 2020-06-30 | MNPR | Option Ex | 323 | .00 | 0 |
| 2020-03-31 | MNPR | Option Ex | 322 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Starr Christopher M
(Director of Monopar Therapeutics at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.